Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

Back

ESC Professional Premium Access

Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor D. Sa (Funchal, PT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

0 follower

6 more presentations in this session

Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

Speaker: Doctor F. Wenzl (Zurich, CH)

Access

Abstract

Slides

Prevalence of coronary atherosclerosis in individuals with pre-diabetes and diabetes compared to normoglycemic individuals

Speaker: Professor C. Ostgren (Linkoping, SE)

Access

Abstract

Slides

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Speaker: Doctor J. Li (Beijing, CN)

Access

Abstract

Slides

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and mortality in type 1 diabetes

Speaker: Doctor H. Segersvard (Helsinki, FI)

Access

Abstract

Slides

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Speaker: Doctor P. Haller (Boston, US)

Access

Abstract

Slides

Access the full session

Coronary artery disease - Epidemiology, prognosis, outcome 5

Speakers: Doctor D. Sa, Doctor F. Wenzl, Professor C. Ostgren, Doctor J. Li, Doctor H. Segersvard...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources